These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36435565)

  • 1. Management of COVID-19 in Patients with Pulmonary Arterial Hypertension.
    Farmakis IT; Giannakoulas G
    Heart Fail Clin; 2023 Jan; 19(1):107-114. PubMed ID: 36435565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial hypertension and COVID-19: Piecing the puzzle.
    Charif F; Dakroub F; Bou Akl I; Kularatne M; Montani D
    Respir Med Res; 2023 Nov; 84():101053. PubMed ID: 38236767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of COVID-19 pandemic on the management of pulmonary hypertension.
    Zhou CY; Sahay S; Shlobin O; Soto FJ; Mathai SC; Melendres-Groves L; Mullin CJ; Levine DJ; Kay D; Highland K; Bossone E; Poms A; Memon H; Balasubramanian V; Farmer MJS; Rahaghi F; Elwing JM
    Respir Med; 2023 Jan; 206():107061. PubMed ID: 36493604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Impact on the Process of Care.
    Lee JD; Burger CD; Delossantos GB; Grinnan D; Ralph DD; Rayner SG; Ryan JJ; Safdar Z; Ventetuolo CE; Zamanian RT; Leary PJ
    Ann Am Thorac Soc; 2020 Dec; 17(12):1576-1582. PubMed ID: 32726561
    [No Abstract]   [Full Text] [Related]  

  • 5. Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension.
    Manzi G; Papa S; Mariani MV; Scoccia G; Filomena D; Malerba C; Adamo FI; Caputo A; De Lazzari C; De Lazzari B; Cedrone N; Madonna R; Recchioni T; Serino G; Vizza CD; Badagliacca R
    Vascul Pharmacol; 2022 Aug; 145():107024. PubMed ID: 35716991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic.
    Serati A; Keshmiri MS; Shafaghi S; Mohammad MM; Kashani BS; Naghashzadeh F; Mohamadifar A; Shafaghi M; Noorali S; Hajimoradi M; Astani B; Aghdasi S; Riahi M; Alavi S; Malek R; Movahed MR
    Crit Pathw Cardiol; 2023 Jun; 22(2):60-64. PubMed ID: 37220659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.
    Wesley Milks M; Sahay S; Benza RL; Farber HW
    J Heart Lung Transplant; 2021 Mar; 40(3):172-182. PubMed ID: 33414063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary arterial hypertension.
    Luna-López R; Ruiz Martín A; Escribano Subías P
    Med Clin (Barc); 2022 Jun; 158(12):622-629. PubMed ID: 35279313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registry.
    Salvador ML; Rodríguez-Padial L; Soto Abánades C; Cruz Utrilla A; Barberá Mir JA; López-Meseguer M; Segovia Cubero J; Samper GJ; Blanco Vich I; Escribano-Subías P; ;
    J Intern Med; 2022 Jul; 292(1):116-126. PubMed ID: 35184348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension.
    Takaya Y; Akagi T; Sakamoto I; Kanazawa H; Nakazawa G; Murakami T; Yao A; Nanasato M; Saji M; Hirokami M; Fuku Y; Hosokawa S; Tada N; Matsumoto K; Imai M; Nakagawa K; Ito H
    Heart; 2022 Mar; 108(5):382-387. PubMed ID: 34415851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.
    Lewis C; Sanderson R; Vasilottos N; Zheutlin A; Visovatti S
    Heart Fail Clin; 2023 Jan; 19(1):45-54. PubMed ID: 36435572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal Management and Long-Term Follow-up of a Primipara With Severe Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus.
    Song W; Chu S; Yang K; Sun X; Xia H; Mei C; Zhao Y; Wu J
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2511-2517. PubMed ID: 34247927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing Pulmonary Arterial Hypertension With Cardiopulmonary Comorbidities.
    Provencher S; Mai V; Bonnet S
    Chest; 2024 Mar; 165(3):682-691. PubMed ID: 38461018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for the Treatment of Pulmonary Arterial Hypertension.
    Vazquez ZGS; Klinger JR
    Lung; 2020 Aug; 198(4):581-596. PubMed ID: 32671468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future].
    Martynyuk TV; Chazova IE
    Ter Arkh; 2021 Sep; 93(9):1009-1017. PubMed ID: 36286859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines.
    Dinarti LK; Anggrahini DW; Lilyasari O; Siswanto BB; Hartopo AB
    Glob Heart; 2021 Apr; 16(1):23. PubMed ID: 34040936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary arterial hypertension in pregnancy.
    Vaidy A; Vaidya A
    Curr Opin Cardiol; 2023 May; 38(3):250-256. PubMed ID: 36811622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
    Ruopp NF; Cockrill BA
    JAMA; 2022 Apr; 327(14):1379-1391. PubMed ID: 35412560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis.
    Farmakis IT; Vazakidis P; Doundoulakis I; Arvanitaki A; Zafeiropoulos S; Boutou A; Karvounis H; Giannakoulas G
    Pulm Pharmacol Ther; 2021 Jun; 68():102036. PubMed ID: 33979684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future.
    Zhao J; Wang Q; Deng X; Qian J; Tian Z; Liu Y; Li M; Zeng X
    Pharmacol Ther; 2022 Nov; 239():108192. PubMed ID: 35461923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.